Geoffrey W. Bergman, M.B., B.S.

Dr. Safdieh is the Gertrude Feil Associate Dean of Curricular Affairs, Vice Chair for Education and Professor of Neurology at Weill Cornell Medicine. He received his bachelors degree in neuroscience, summa cum laude, from the College of Arts and Science of New York University. He received his medical degree (MD) from the New York University School of Medicine, where he received the Alpha Omega Alpha Award for graduating first in his class. He completed his neurology residency training at the Weill Cornell Campus of New York Presbyterian Hospital, where he also served as Chief Resident in the Department of Neurology. Dr. Safdieh is a member of Phi Beta Kappa and Alpha Omega Alpha, the medical honors society.Dr. Safdieh was the director of the medical student Neurology Clerkship for the Weill Cornell Medical College, the medical director of the Neurology Clinic at New York-Presbyterian Hospital and also served as Director of Outpatient Training for the Neurology Residency Program As associate dean, he is responsible for overseeing the curriculum at Weill Cornell Medicine. He is well respected as an innovative medical educator, and has developed numerous curricula for the teaching of neurology to both medical students and other physicians. He has been recognized for his excellence in medical student education locally, nationally and internationally. Dr. Safdieh has served in various committe roles with the American Academy of Neurology, where he is currently vice chair of the publications committee. He served as chair of the Consortium of Neurology Clerkship Directors. He is currently editor-in-chief of Neurology Today, the official news source of the American Academy of Neurology.

Dr. Saxena is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the NewYork-Presbyterian Hospital. He graduated from the Medical Scientist Training Program at Stony Brook University, receivinghis MD and a PhD in Genetics. Following this he completedhis residency in internal medicine at Montefiore Medical Center and fellowship in Hematology/Oncology at Weill Cornell Medical College-New York-Presbyterian Hospital. After fellowship Dr. Saxena worked as a post-doctoral research fellow at the Sloan Kettering Institute of the Memorial Sloan Kettering Cancer Center where his research focused on the study of exosomes. He returned to Weill Cornell Medical College in 2015 to join the facultyof the Division of Hematology and Medical Oncology in their Thoracic Oncology program.Dr. Saxena's clinical and research interests have beenin the study and management of different forms of lung cancer. He currentlytreats patients with non-small cell andsmall-cell lung cancers, mesothelioma, thymoma, and sarcomas of the lung. He is involved in both clinical and laboratory research, collaborating with physicians and scientists at Weill Cornell as well asother institutions.

Moises Dominguez, M.D., is an Assistant Professor of Neurology at Weill Cornell Medical College, specializing in headache medicine.He earned his Bachelor of Science in biology and a minor in philosophy from the City College of New York, where he graduated summa cum laude. He then obtained his doctor of medicine degree from Yale University School of Medicine and completed his thesis on optimizing the educational experience of medical students rotating on neurology using a video-based model of learning and Just-in-time teaching. He completed his neurology training at NewYork-Presbyterian Hospital (Weill Cornell Campus) and Memorial Sloan Kettering Cancer Center, where he was elected by his peers to be chief resident and won the Neurology Resident Teaching Award. After graduating from Weill Cornell, he completed his Headache Medicine fellowship at New York University, a United Council for Neurologic Subspecialties-accredited fellowship program.Dr. Dominguez has published several articles on medical education and headache-related topics, as well as book chapters in the field of headache disorders and its procedural and neuromodulatory treatment. He previously served as an assistant editor for the journal Headache, a leader in publishing literature in headache and facial pain disorders, and is the official journal of the American Headache Society. Additionally, he is on the editorial board of the American Migraine Foundation, a nonprofit organization focused on promoting research, advocacy, and awareness for people with migraine. He has a strong interest in education and innovative methods of treating migraine and other headache disorders, including pharmacological, procedural, and device-based modalities.